About PathologyWatch
PathologyWatch is a Healthcare company based in Salt Lake City (United States) founded in 2018 by Dan Lambert, Michael Torno, and Gregory Osmond, and was acquired by Sonic Healthcare in November 2023. Clinical workflow software and services are provided for pathology professionals. PathologyWatch has raised $34.34 million across 4 funding rounds from investors including Sonic Healthcare, Ceros Capital Markets and Rock Creek Capital. Its chief executive, as recorded, is Dan Lambert. PathologyWatch offers products and services including Digital Slides Access and EMR Integration. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include 3Derm, Love My Delta and RealizeMD; 2 of its 3 listed competitors have raised funding.
Company details
PathologyWatch offers clinical workflow management and decision-making software and services for professionals. The software platform enables the pathologist to upload a digital sample of slides in the cloud and automate the result to their EHR system for hospital operations. The company provides services for digital pathology, dermatopathology where samples can be sent to the company for biopsy and interpretation. Products like PathologyWatch, ValueWatch, and Business watch assist with the laboratory functions and operations like remote image viewing, Electronic Medical Records integration, and more.
- Headquarters Salt Lake City, United States
- Founders Dan Lambert, Michael Torno, Gregory Osmond
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pathologywatch.com
- Social LinkedIn X
- Acquired by Sonic Healthcare (Nov 2023)
- Total Equity Funding$34.34M (USD)
in 4 rounds
- Latest Funding Round$25M (USD), Series B
Nov 2021
- InvestorsSonic Healthcare
& 13 more
- Acquired bySonic Healthcare
(Nov 2023)
Products & Services of PathologyWatch
PathologyWatch offers a comprehensive portfolio of products and services, including Digital Slides Access and EMR Integration.
Provides 24/7 access to digital pathology slides for review
Automates report integration into electronic medical records for efficiency
Funding Insights of PathologyWatch
PathologyWatch has successfully raised a total of $34.34M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.34M
- Total Rounds 4
- Last Round Series B — $25M
- First Round $2.34M
(May 2019)
- Investors Count 13
All 4 funding rounds of PathologyWatch with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $25M | Series B | – | Ceros Capital Markets, Spark Growth Ventures | |
| Dec 2020 | $2M | Series A | – | Neue Fund, Bioventure | |
| May 2020 | $5M | Series A | – | Rock Creek Capital, SpringTide | – |
| May 2019 | $2.34M | Seed | – | – | – |
14 investors in total: 14 institutional.
Investors in PathologyWatch
PathologyWatch has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Sonic Healthcare, Ceros Capital Markets and Rock Creek Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are focused on tech startups. | ceroscapitalmarkets.com | Miami, United States | ||
Private equity and venture investments are provided to build businesses. | rockcreekcapllc.com | Salt Lake City, United States | ||
Early-stage tech startups are invested in by Spark Growth Ventures. | sparkgv.com | San Diego, United States | ||
A community of healthcare entrepreneurs is supported by Blueprint Health. | blueprinthealth.org | |||
AI and software companies are invested in by JBV Capital. | jbvcap.com | San Francisco, United States | ||
| brooksmgtgroup.com | ||||
| neuefund.com | ||||
Venture capital fund focused on multiple sectors | lateralcapital.com | Sarasota, United States | ||
Early-growth stage capital is provided to technology ventures. | benivc.com | |||
| sky-ventures.com |
Investor details for PathologyWatch
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PathologyWatch
71 people are tracked at PathologyWatch (14 in leadership, 8 in board & advisors, 49 in team).
| Name | Role | Group |
|---|---|---|
Dan Lambert | Co-Founder & CEO | Leadership |
Michael Torno | Co-Founder | Leadership |
Gregory Osmond | Co-Founder | Leadership |
Nicole Crawford | Vice President Operations | Leadership |
Raphael Mace | Director Of Information Technology | Leadership |
Thatcher Risom | VP Engineering | Leadership |
April Larson | CMO and Co-Founder | Leadership |
Scott Mattivi | Chief Operations Officer | Leadership |
Aaron Christensen | Senior Sales Director | Leadership |
Rachel Reeg | Senior Sales Director - Digital Dermatopathology | Leadership |
Tiffany T | Digital Dermatopathology Sales Director | Leadership |
Jeff Hester PhD | Chief Scientific Officer | Leadership |
James Requoa | VP of AI | Leadership |
Evan Cancelliere | Director of Digital | Leadership |
Faramarz Samie | Advisor | Board & advisors |
Austin Walters | Investor and Board Member | Board & advisors |
Shane Chapman | Advisor | Board & advisors |
Richard Levenson | Advisor | Board & advisors |
Nicole Pace | Advisor | Board & advisors |
Sancy Leachman | Advisor | Board & advisors |
51 more people are available in the full profile.
Complete people profiles for PathologyWatch
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PathologyWatch
4 dated milestones of PathologyWatch across 5 years, from founding to its latest funding, stage changes and deals.
- Founded PathologyWatch is founded.
- Funding First funding round of $2.3M.
- Funding Latest funding round, Series B, of $25.0M.
- Exit Acquired by Sonic Healthcare.
Competitors of PathologyWatch
PathologyWatch has 3 listed competitors in our database, 2 of them funded. They include 3Derm, Love My Delta and RealizeMD.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 3derm.com | 2012 | New Haven, United States | $2.16M | 41 | Skin images are analyzed digitally for disease detection by dermatologists. | |
| lovemydelta.com | 2020 | Philadelphia, United States | $3.17M | AI-based skin analysis tool for wellness, beauty, and aesthetic medicine | ||
| realizemd.com | 2019 | New York, United States | An AI-driven visual data platform for medical aesthetics is developed. |
Detailed competitors of PathologyWatch
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PathologyWatch
The website of PathologyWatch (pathologywatch.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 25% vs previous month
Websites whose visitors overlap most with PathologyWatch. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ilds.org | ilds.org | 100% | #1,813,423 | – |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as PathologyWatch (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pathologywatch
Complete news archive for PathologyWatch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PathologyWatch
PathologyWatch was founded in 2018 and raised its 1st funding round 1 year after it was founded.
PathologyWatch is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Dan Lambert is the CEO of PathologyWatch, as recorded in our data. They have also founded this company.
PathologyWatch is a funded company, having raised a total of $34.34M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.34M, raised on May 2019.
PathologyWatch offers clinical workflow management and decision-making software and services for professionals. The software platform enables the pathologist to upload a digital sample of slides in the cloud and automate the result to their EHR system for hospital operations. The company provides services for digital pathology, dermatopathology where samples can be sent to the company for biopsy and interpretation. Products like PathologyWatch, ValueWatch, and Business watch assist with the laboratory functions and operations like remote image viewing, Electronic Medical Records integration, and more.
PathologyWatch's top competitors include 3Derm, Love My Delta and RealizeMD.
PathologyWatch offers Digital Slides Access and EMR Integration.
PathologyWatch has 14 investors. Key investors include Sonic Healthcare, Ceros Capital Markets, Rock Creek Capital, Spark Growth Ventures, and Blueprint Health.
Yes. PathologyWatch was acquired by Sonic Healthcare in November 2023.